The current study revealed the protective effects of HBO treatment against HFD-induced fatty acid metabolism dysfunction/obesity, as well as the roles of L-carnitine and associated PPAR signaling. The gene discussed is PPARA; the disease is obesity due to melanocortin 4 receptor deficiency.